This company has been marked as potentially delisted and may not be actively trading. Nymox Pharmaceutical (NYMX) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock NYMX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Nymox Announces Filing of Annual ReportAugust 31, 2024 | markets.businessinsider.comNymox Annual ReportJuly 20, 2024 | finance.yahoo.comNymox December 27 Message to ShareholdersDecember 27, 2023 | markets.businessinsider.comNymox Pharmaceutical Corporation: Nymox December 27 Message to ShareholdersDecember 27, 2023 | finanznachrichten.deNymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutler and OthersNovember 30, 2023 | finance.yahoo.comNymox Pharmaceutical Corporation: $250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California CourtNovember 22, 2023 | finanznachrichten.de$250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California CourtNovember 21, 2023 | markets.businessinsider.comNymox Pharmaceutical Corporation Sues AscellaHealth For $250 MillionNovember 9, 2023 | markets.businessinsider.comThe Committee to Restore Nymox Shareholder Value Provides Factual Update to Nymox Shareholders Regarding Special MeetingNovember 6, 2023 | finance.yahoo.comNYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023November 3, 2023 | financialpost.comFNotice: Nymox Informs Its Shareholders Not to Take Calls or Participate in An Unauthorized and Improper Shareholder MeetingOctober 27, 2023 | benzinga.comNymox Pharmaceutical Corporation: Nymox Reports New NYMOZARFEX Marketing Application is Accepted For ReviewOctober 26, 2023 | finanznachrichten.deThe Committee to Restore Nymox Shareholder Value Issues Notice of Special Meeting of Nymox Pharmaceutical ShareholdersOctober 11, 2023 | finance.yahoo.comBahamas Supreme Court Rules in Favor of Committee to Restore Nymox Shareholder Value: Orders Shareholder Meeting, Grants Injunction Freezing CEO SharesOctober 6, 2023 | businesswire.comNymox Pharmaceutical Corporation (NYMXF)September 26, 2023 | finance.yahoo.comNymox Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPHSeptember 25, 2023 | markets.businessinsider.comNymox Reports Completion of $2 Million Private PlacementAugust 29, 2023 | markets.businessinsider.comNymox Pharmaceutical Corporation: Nymox Reports on U.S. Patent IssuancesJuly 18, 2023 | finanznachrichten.deNymox Reports on U.S. Patent IssuancesJuly 18, 2023 | finance.yahoo.comThe Committee to Restore Nymox Shareholder Value Soundly Rebuts Injurious Allegations Made by Nymox Pharmaceutical Corp Current ManagementJuly 16, 2023 | venturebeat.comVNymox Announces Appointment Of Patrick Doody as Vice President and Member of the Board of Directors of NymoxJuly 12, 2023 | finance.yahoo.comRebuttal Letters Issued to Shareholders of NYMOX PHARMACEUTICAL CORP (“NYMX-Q”)July 9, 2023 | venturebeat.comVNymox Pharmaceutical Corporation: NYMOX UpdateJuly 8, 2023 | finanznachrichten.deNYMOX UpdateJuly 7, 2023 | financialpost.comFWhy Is Nymox Pharmaceutical (NYMX) Stock Down 18% Today?July 6, 2023 | investorplace.comNymox Pharmaceutical receives potential delisting notice from NasdaqJuly 6, 2023 | seekingalpha.comNYMX Tanks after Receiving Delisting NoticeJuly 6, 2023 | msn.comNymox Delisting from NASDAQJuly 5, 2023 | financialpost.comFNYMX - Nymox Pharmaceutical CorporationJune 30, 2023 | finance.yahoo.comNymox Pharmaceutical (NYMX) Stock Down After Disappointing Enlarged Prostate Treatment Test ResultsJune 27, 2023 | thestreet.comNymox Pharmaceutical (NASDAQ: NYMX)June 15, 2023 | fool.comNymox Pharmaceutical Corporation: Nymox Provides Current UpdateMay 10, 2023 | finanznachrichten.deNymox Provides Corporate UpdateApril 3, 2023 | finance.yahoo.comNymox Announces Appointment of Christopher R. Riley as Chief Financial OfficerMarch 21, 2023 | finance.yahoo.comNymox Officially Granted Extension to Regain Listing RequirementsMarch 15, 2023 | finance.yahoo.comOne Nymox Pharmaceutical Corporation (NASDAQ:NYMX) insider upped their stake by 32% in the previous yearMarch 6, 2023 | finance.yahoo.comNymox Announces NYMOZARFEX Marketing Application is Accepted For ReviewFebruary 15, 2023 | finance.yahoo.comNYMOX Appeals Deficiency LetterJanuary 6, 2023 | finance.yahoo.comNYMOX Announces New Marketing Submission for NYMOZARFEX™ for BPHDecember 5, 2022 | finance.yahoo.comMay 2023 Market Cap Requirement UpdateNovember 25, 2022 | financialpost.comFA Nymox Pharmaceutical Corporation (NASDAQ:NYMX) insider increased their holdings by 32% last yearSeptember 27, 2022 | finance.yahoo.comWe Think Nymox Pharmaceutical (NASDAQ:NYMX) Needs To Drive Business Growth CarefullyAugust 17, 2022 | nasdaq.comU.S. shares higher at close of trade; Dow Jones Industrial Average up 2.15%July 15, 2022 | msn.comNYMOX Updates ShareholdersJuly 15, 2022 | finance.yahoo.comNYMOX Receives Deficiency Letter from NASDAQJuly 14, 2022 | finance.yahoo.comNymox Pharmaceutical Down 64% on FDA Refusal to File LetterMay 23, 2022 | marketwatch.comNYMOX Receives RTF letter from FDAMay 23, 2022 | stockhouse.comNYMOX down 46% on Refuse to File letter from FDA for fexapotide for enlarged prostateMay 23, 2022 | seekingalpha.comNymox Application for Fexapotide Triflutate Rejected by FDA >NYMXMay 23, 2022 | marketwatch.comWhy Nymox Pharma Shares Sinking to 52-Week Low?May 23, 2022 | benzinga.com Get Nymox Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for NYMX and its competitors with MarketBeat's FREE daily newsletter. Email Address NYMX Media Mentions By Week NYMX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NYMX News Sentiment▼0.000.49▲Average Medical News Sentiment NYMX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NYMX Articles This Week▼00▲NYMX Articles Average Week Get Nymox Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for NYMX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VolitionRx News Inotiv News Immix Biopharma News Veru News Apyx Medical News Sutro Biopharma News Agape ATP News Assertio News Pyxis Oncology News Genenta Science News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NYMX) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nymox Pharmaceutical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nymox Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
